Raymond James & Associates’s Madrigal Pharmaceuticals MDGL Stock Holding History

Raymond James & Associates’s Portfolio MDGL Stock Details MDGL Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$4.12M	Sell
2024 Q2	$5.69M	Buy
2024 Q1	$5.42M	Buy
2023 Q4	$4.57M	Sell
2023 Q3	$2.99M	Buy
2023 Q2	$3.5M	Buy
2014 Q1	–	Sell
2013 Q4	$475K	Buy